QUADRANT CAPITAL GROUP LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,730906
+3675.0%
0.00%
Q1 2022$0240.0%0.00%
Q4 2021$0
-100.0%
24
-60.7%
0.00%
Q3 2021$1,00061
+369.2%
0.00%
Q1 2021$013
-13.3%
0.00%
Q1 2020$0150.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders